Our results indicated that, of the selective 10 tumor-promoting genes of TAMs, only MMP19 (Figure 6A), and SIRPα (Figure 6B) can predict ICB response in ICC patients. The gene discussed is SIRPA; the disease is intrahepatic cholangiocarcinoma.